Academic journal publications:
Parvanova, I. and Lagarde, M. (2024), Framing of sensitive topics in surveys measuring corruption in healthcare. Social Science and Medicine, https://doi.org/10.1016/j.socscimed.2024.117521
Gentilini, A. and Parvanova, I. (2024), Managing experts’ conflicts of interest in the EU Joint Clinical Assessment. BMJ Open, https://bmjopen.bmj.com/content/14/11/e091777
Parvanova, I. (2024). Institutional characteristics and social norms as drivers of petty corruption in healthcare - a multilevel latent class analysis. Governance, https://doi.org/10.1111/gove.12868
Osipenko, L., Potey, P., Perez, B., Angelov, F., Parvanova, I., Ul-Hasan, S. and Mossialos, E. (2024), The Origin of First-in-Class Drugs: Innovation Versus Clinical Benefit, Clinical Pharmacology & Therapeutics, https://doi.org/10.1002/cpt.3110
Parvanova, I., Gentilini, A., Cushing, J., & Naci, H. (2023). Safeguarding NICE from patient groups’ conflicts of interest. BMJ, 381, https://doi.org/10.1136/bmj.p1243
Gentilini, A. and Parvanova, I. (2023) Industry funding of patient organisations in the United Kingdom: a retrospective study of commercial determinants, funding concentration and disease prevalence. BMJ Open, http://dx.doi.org/10.1136/bmjopen-2022-071138
Under review
Informal payments for healthcare - international comparisons (Forthcoming book chapter, with Dr Sara Allin (University of Toronto) and Dr Ilias Kyriopoulos (LSE))
Upholding Integrity - The causes and trends of corruption in Europe - 41 (Forthcoming report for the European Commission, with Professor Alina Mungiu-Pippidi (LUISS))
Work in progress
Favoritism and corrupt reciprocity - a lab-in-the-field experiment (with Dr Mylene Lagarde (LSE))
Corruption in the supply chain of generic antibiotics - assessing the drivers of counterfeit and falsified drugs (with Transparency International)
A retrospective study of conflicts of interest in the French pharmaceutical industry (with Arianna Gentilini (LSE) and Prof Jillian Kohler (Univeristy of Toronto))
Conflicts of interests and patients organizations - a literature review (with Arianna Gentilini (LSE) and Prof Jillian Kohler (Univeristy of Toronto))
Evidence on the implementation and effectiveness of administrative anti-corruption interventions and their lessons for the healthcare system - a systematic review of evaluations (with Prof Dina Balabanova (LSHTM))
Mapping corruption risks across Europe using the UNODC Corruption Risk Matrix (with Prof Alina Mungiu-Pippidi (LUISS))
Measuring the gap between objective and subjective measures of corruption in EU member states and accession candidates (with Prof Alina Mungiu-Pippidi (LUISS))
Media coverage and interviews
Doctor bribes: Romania finds rare success among persisting healthcare corruption across Europe, BMJ, https://www.bmj.com/content/384/bmj.q307 [23 February 2024]
Revealed: Drug firms funding UK patient groups that lobby for NHS approval of medicines, The Guardian, https://www.theguardian.com/science/2023/jul/22/revealed-drug-firms-funding-uk-patient-groups-that-lobby-for-nhs-approval-of-medicines [23 July 2023]
Why economics has a problem with women, Open Democracy, https://neweconomics.opendemocracy.net/index.html%3Fp=2561.html, [7 March 2018]
Economics teaching is still neglecting critical thought, The Guardian, https://www.theguardian.com/business/economics-blog/2016/nov/17/economics-teaching-is-still-neglecting-critical-thought, [17 November 2016]
How might Scottish universities change outside the EU?, BBC, https://www.bbc.co.uk/news/uk-scotland-37966846, [14 November 2016]